Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
about
Evolutionary history and attenuation of myxoma virus on two continentsImmunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified riskInfectivities of human and other primate lentiviruses are activated by desialylation of the virion surfacePotential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expressionEnvelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophagesThe cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1.In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropismHIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell declineNovel alleles of the chemokine-receptor gene CCR5.Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.Molecular and biological analyses of quasispecies during evolution of a virulent simian immunodeficiency virus, SIVsmmPBj14.The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN.Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses.Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entryDivergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptorTwo distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env.
P2860
Q21558784-65336A3B-A738-4355-A981-724E97BB09C9Q24531479-A3CD04D3-F2C7-4AD8-A418-EE2AC1DEEE34Q24654734-FCAC9667-E0C7-47DC-94D4-DA74B4A13235Q24680171-6DCBDE41-8EDE-4FCC-83AA-5FFB054C607BQ30413754-20C1C7E4-B450-4584-AF29-BD84B84E917AQ30448634-BBDE9038-BEF5-4F93-B756-E88D771A6524Q33636669-1705B7F0-3E24-4B07-AB3E-96C125E5DCD4Q33650466-390824F0-28EB-4E67-81AF-876D3EBDCD53Q33724200-CB964E32-C026-4482-A92C-AFFF3AC7D0F2Q33782350-949EFA66-3D7D-4863-A48D-E46E788AE8C8Q33783481-9C19C850-7539-4179-AD47-B3AF8D0414E7Q33784206-48DE79FC-DAE0-4D8A-A369-0333DDF5E695Q33784321-47F85528-F9E2-4FAB-92C2-3E56C64BAE66Q33784708-DA8DACDA-DE3B-4320-8F73-F4E7FB53FDB8Q33785473-72CD329E-6896-454C-B6E3-3D98E2D69692Q33810203-0187753C-E672-495C-9971-51977E5D551BQ33815193-A7EB6A3D-8559-4DCC-B69E-0CC03DC5B34CQ33887160-B020196D-26C4-4453-8EE9-FF7CD96193E0Q33979799-A6299FA0-97D3-43DD-A2C3-6A3911881D1AQ34170655-D3E0271A-B1E4-4DCD-AA1F-CD92E81B726BQ34464860-5F5CB332-C13C-4B90-8D02-A42CDB78244FQ34717126-5A8B76FC-8034-44F0-A6A0-DA4B627869DAQ35015256-CFDA6FF5-7A50-40ED-95DF-73253F044D0BQ35250327-D7160CF9-8DC4-4B63-B5F0-441B73028A1FQ35681073-ECBFE618-FAFE-496E-88DE-32C2B0A81963Q35704022-B1402807-85BE-479B-86CE-5B91A908CBD6Q35835028-29EC5A8F-269D-4867-A9D5-BFB7C11AFB0EQ35837061-4FAA4A58-FD17-4530-95B7-79BCE1787DFCQ35837877-C12685A0-B960-42EB-AA3D-ECA7BEFDF0B6Q35838430-BF1268F2-7508-44DC-B687-2674FEAE01BCQ35861228-18EE5ECF-E7AB-4FDD-BB19-3AA010BA2BE0Q35862161-6919B85D-DA04-4169-847B-63F87011866CQ35866513-768E7AEC-AF64-47E6-86B5-76DCDC9E1652Q35871314-7FE53886-9930-4EE8-9DEB-00BAB946ECFFQ35880381-E478B9B7-2ECA-41FB-969D-564A1C741547Q35886136-A482DF2F-6B3E-4690-A9E4-A772FB2927B1Q35887971-48A7C0A0-A649-4021-BABD-5AED38FB4DB5Q35890867-34A6F4B9-406B-4228-B053-7B87D1A816F4Q35890885-B8637E02-E650-48CB-B95A-70A08C957E5DQ35895738-C0D12DF9-3D73-4C68-8C50-3A5CDB3F1CB4
P2860
Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Human immunodeficiency virus t ...... age before disease progression
@ast
Human immunodeficiency virus t ...... age before disease progression
@en
type
label
Human immunodeficiency virus t ...... age before disease progression
@ast
Human immunodeficiency virus t ...... age before disease progression
@en
prefLabel
Human immunodeficiency virus t ...... age before disease progression
@ast
Human immunodeficiency virus t ...... age before disease progression
@en
P2860
P1433
P1476
Human immunodeficiency virus t ...... age before disease progression
@en
P2093
P2860
P304
P407
P577
1994-07-01T00:00:00Z